|
|
|
|
|
Legal status
Patent not validated
| (51) | INT.CL. | A61K 39/00 | |
| G01N 33/569 | |||
| G01N 33/68 | |||
| C07K 16/28 |
| (11) | Number of the document | 2279004 |
| (13) | Kind of document | T |
| (96) | European patent application number | 09747765.7 |
| Date of filing the European patent application | 2009-05-18 | |
| (97) | Date of publication of the European application | 2011-02-02 |
| (45) | Date of publication and mention of the grant of the patent | 2015-01-14 |
| (46) | Date of publication of the claims translation |
| (86) | Number | PCT/US2009/044375 |
| Date | 2009-05-18 |
| (87) | Number | WO 2009/140684 |
| Date | 2009-11-19 |
| (30) | Number | Date | Country code |
| 54115 P | 2008-05-16 | US |
| (72) |
GELZLEICHTER, Thomas, Richard, US
HIRARAGI, Hajime, US
STEFANICH, Eric, Gary, US
WANG, Hong, US
WILLIAMS, Marna Bromberg, US
|
| (73) |
F. Hoffmann-La Roche AG,
Grenzacher Strasse 124, 4070 Basel,
CH
|
| (54) | USE OF BIOMARKERS FOR ASSESSING TREATMENT OF GASTROINTESTINAL INFLAMMATORY DISORDERS WITH BETA7INTEGRIN ANTAGONISTS |
| USE OF BIOMARKERS FOR ASSESSING TREATMENT OF GASTROINTESTINAL INFLAMMATORY DISORDERS WITH BETA7INTEGRIN ANTAGONISTS |